INVA FY 2018 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$261M+20.2% YoY

Gross Profit

$261M100.0% margin

Operating Income

$238M91.3% margin

Net Income

$395M151.4% margin

EPS (Diluted)

$3.48

Cash Flow

Operating Cash Flow

$224M

Free Cash Flow

$224M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$548M

Total Liabilities

$389M

Stockholders' Equity

$154M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$261M	$217M	+20.2%
Gross Profit	$261M	$216M	+20.9%
Operating Income	$238M	$184M	+29.8%
Net Income	$395M	$134M	+194.5%